This striking observation was in discordance with major leading reports about the genomic landscape of AML (DiNardo et al., 2016; Papaemmanuil et al., 2016) who found that the frequency of co-occurring NPM1 mutation seems higher in the presence of IDH1/2 mutations (65% vs. 48%). The gene discussed is IDH1; the disease is acute myeloid leukemia.